Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency

Clinical trial NCT07129759 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07129759
Sponsor: Lumos Pharma
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Growth Hormone Deficiency (GHD)

Start date: 2027-02-01
Primary completion: 2030-02-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.